Sona Nanotech Advances Cancer Therapy Research
Company Announcements

Sona Nanotech Advances Cancer Therapy Research

Story Highlights

Sona Nanotech Inc (TSE:SONA) has released an update.

Sona Nanotech Inc. is showcasing its Targeted Hyperthermia Therapy (THT) cancer treatment at the NCL’s 20th anniversary symposium, celebrating advances in cancer nanotechnology. The company has successfully completed initial safety studies for its gold nanorods, paving the way for further human trials in 2025.

For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Secures Patent and Strengthens Leadership
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Awards Stock Options and Advances Cancer Therapy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App